CIPA Guide to the Patents Acts

Bringing together the expertise of over 25 highly respected professionals including patent attorneys, solicitors and members of the Bar individually selected for knowledge of and insight into the subjects to which they contribute, this essential guide gives you all the tools you need to protect the rights of your clients. Features a unique section-by-section guide to all relevant Patents Legislation including Patents Act, Patents Rules and relevant sections of Copyright, Patents and Designs Acts Includes the complete text of each section and of any relevant Patents Rules, Civil Procedure Rules and practice directions Provides detailed commentary and analysis accompanies each section of each Act Provides extensive commentary on the interpretation of each section by the UK-IPO and courts and on relevant case law of the EPO Appeal Boards Explores the relevant case law of the UK courts, IP Office and EPO Appeal Boards for each section Refers to over 3300 case decisions with in-depth of analysis of both reported and significant unreported decisions Offers extensive analysis of case law as it relates to each section and provides a clear guide as to what the Courts have decided and why Presents practical insight into the common technical and legal issues that can arise and shows how best to handle them Acts as a practical guide to the current requirements of and procedures before the UK-IPO and the UK courts Offers a practical guide to the practice that has developed in relation to each section NEW FOR 8TH EDITION Coverage of legislative and jurisprudence developments to end June 2015, including: Amendments introduced by recent legislation including the Intellectual Property Act, 2014, the Patents (European Patent with Unitary Effect and Unified Patents Court) order 2015, the Patents (Amendment) Rules 2014 and updates to CPR Practice Direction 63. Substantial commentary on landmark decisions including: Lantana Ltd v Comptroller General of Patents [2014] EWCA Civ 1463 (patentable subject matter) Aga Medical Corp v Occlutech (UK) Ltd [2014] EWHC 2506 (Pat) (confidentiality) Teva UK Limited & another v AstraZeneca AB [2014] EWHC 2873 (Pat) (obviousness; common general knowledge) Idenix v Gilead [2014] EWHC 3916 (generic claim for pharmaceutical compounds; rationale supporting effectiveness) Warner-Lambert v Actavis [2015] EWCA Civ 556 (medical use claims) International Stem Cell Corporation (Judgment) [2014] EUECJ C-364/13 (human embryo) Eli Lilly & Company v Human Genome Sciences Inc [2014] EWHC 2404 (Pat) (SPC regulation) T 1363/12 SAMSUNG/Reinforcement (test for added subject-matter) G 3/14 Examination of clarity objections G 2/12 Tomatoes II and G 2/13 Broccoli II (product claims; essentially biological processes) Commentary on the many other decisions recently handed down which may be relevant to specific practice